Skip to main content
. 2021 May 31;11(6):416. doi: 10.3390/membranes11060416

Table 1.

Case series describing at least 5 patients undergoing thoracic or airway reconstruction procedure on ECMO or ECCO2R.

Author, Year Indications for ECMO or ECCO2R Prevalent Types of Surgery Number of Patients
(Configuration: Cannulation)
Intraoperative
Heparin
Time on ECMO or ECCO2R ECMO-Related
Complications
Hospital/30-Day Mortality
Wiebe K, 2010 [11] 6 single lung
4 LLF due to ARDS
5 tracheal resection or repair
4 lung resection
1 partial decortication
10 (pumpless ECCO2R: V 19F fem-A 17F fem) can 500–1000 IU
none
6 intraop.
4 postop. for 6.8 days
1 retroperitoneal hematoma 2/10 (20%) in total
0/4 (0%) elective
2/6 (33%) urgent
Chang X, 2014 [21] 7 CTBR 7 tracheal resection 7 (VA: V 19F fem-A 17F fem) can 200 IU/kg
ACT 300 s
10–31 min none 0/7 (0%)
Redwan B, 2015 [14] 5 single lung
3 LLF
1 carinal resection
7 pulmonary resection
2 extended metastasectomy
1 carinal PE
9 (3 VV: V 25F fem-V 21 IJV; 6 ECCO2R: 24 F DL fem) 2000–4000 IU
none
129 ± 40 min
intraop. only
not reported 1/9 (11%)
Lang G, 2011 [15]
Lang G, 2015 [22]
8 CTBR
2 LLF
6 carinal resection
3 sleeve (bi)lobectomy
1 sleeve PE
10 (VA: 7 central RA-AoA + 3 peripheral fem-fem) can 3000–5000 IU
none
113 ± 17 min
intraop. only
none 0/10 (0%)
Rinieri P, 2015 [16] 23 CTBR
5 single lung
5 LLF including trauma
3 ECMO preoperatively
tracheal/carinal reconstruction,
wedge resection to PE,
lymphadenectomy
36 (16 VA: 6 central + 10 peripheral; 20 VV; 5 ECCO2R) can 50–100 IU/kg
ACT 160–200 s
median 65 min for VA and 78 min for VV ECMO, many postop. 7 reoperations due to bleeding (6 operation site, 1 cannulation site) 6/36 (17%) in total
1/27 (4%)
elective
5/9 (56%) urgent
Kim SH, 2017 [23] 6 post-intubation or post-tracheostomy stenosis tracheal/carinal reconstruction 9 (1 VA: peripheral; 8 VV: 6 fem-fem + 2 fem-IJV) can 50–100 IU/kg
ACT 150–180 s
7 intra-op. for 1.5–4 h, 2 postop none 1/9 (11%)
0/6 elective
1/3 (33%) urgent
Akil A, 2020 [13] 65 emphysema with hypercapnia 65 LVRS 65 (ECCO2R: 24F DL fem or 22F DL IJV) none all postop., mean 3 days 1 disseminated intravascular coagulopathy 90-day mortality
5/65 (8%)
Kim CW, 2015 [24]
Kim DH, 2021 [25]
27 LLF (pneumonia etc.)
19 airway disease
27 lung resection
19 airway surgery
17 others
63 (21 VA: peripheral fem-fem; 42 VV fem-IJV) can 50–70 IU/kg
none
mean 4.5 days postop. not reported 17/63 (27 %) in total
9/11 (82%) eCPR
Koryllos A, 2021 [9] 8 CTBR
16 left lung and descending aorta or left atrium resection
sleeve lobectomy or PE,
lobectomy or PE with left atrial or aortic resection
24 (7 VA fem-fem; 9 VV-A fem+IJV-fem; 8 VV: 7 fem-IJV + 1 fem-fem) APTT-R 1.5 not reported 2 reoperations due to bleeding at operation site 6/24 (25%)
mortality of 4 acute cases not reported

Legend: A—arterial, ACT—activated clotting time, AoA—ascending aorta, APTT—activated partial thromboplastin time, can—dose administered before cannulation, CTBR—complex tracheobronchial reconstructions, DL—double lumen cannula, ECCO2R—extracorporeal CO2 removal, ECMO—extracorporeal membrane oxygenation, eCPR—extracorporeal cardiopulmonary resuscitation, F—French, fem—femoral, IJV—internal jugular vein, LLF—limited lung function, LVRS—lung volume reduction surgery, PE—pneumonectomy, RA—right atrium, V—venous; numbers at the beginning of a line represent the number of patients (if stated).